Glutathione S-transferase genotypes in systemic sclerosis and their association with clinical manifestations in early disease
Open Access
- 1 June 2001
- journal article
- research article
- Published by Springer Nature in Genes & Immunity
- Vol. 2 (4) , 236-238
- https://doi.org/10.1038/sj.gene.6363756
Abstract
The glutathione S-transferases (GSTs) are a family of enzymes involved in limiting oxidative damage to tissues. Null alleles for one or more of the GST enzymes, especially GSTM1, reportedly occur more frequently in patients with Sjögren’s syndrome and systemic lupus erythematosus who possess certain autoantibodies. Because systemic sclerosis (SSc) is a disease in which oxidative damage has been hypothesized to contribute both to immune dysfunction and tissue damage, we sought to determine if patients from a multi-ethnic cohort of SSc patients with early disease (5 years) were more likely than ethnically-matched normal controls to have null alleles for GSTM1 (M1) and/or GSTT1 (T1), and if the null allele status correlated with any major disease features. The data show that while M1 and T1 null genotypes were not significantly increased in SSc compared to ethnically matched controls, their frequencies (especially T1 nulls) were significantly higher among SSc patients with hypertension and pulmonary involvement. This suggests that GST genotype may be a genetic factor that contributes to clinical disease expression in SSc.Keywords
This publication has 11 references indexed in Scilit:
- Systemic sclerosis in 3 US ethnic groups: A comparison of clinical, sociodemographic, serologic, and immunogenetic determinantsSeminars in Arthritis and Rheumatism, 2001
- Influence of polymorphism in the manganese superoxide dismutase locus on disease outcome in rheumatoid arthritis: Evidence for interaction with glutathione S-transferase genesArthritis & Rheumatism, 2000
- Association of the glutathione S‐transferase M1 homozygous null genotype with susceptibility to Sjögren's syndrome in Japanese individualsArthritis & Rheumatism, 1999
- Role of metal-catalyzed oxidation reactions in the early pathogenesis of sclerodermaCurrent Opinion in Rheumatology, 1997
- Association of homozygosity for glutathione‐S‐transferase GSTM1 null alleles with the Ro+/La− autoantibody profile in patients with systemic lupus erythematosusArthritis & Rheumatism, 1996
- Autoantibodies to fibrillarin in systemic sclerosis (scleroderma). An immunogenetic, serologic, and clinical analysisArthritis & Rheumatism, 1996
- Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphismBiochemical Journal, 1994
- Glutathione S-transferase GSTM1 phenotypes and protection against cutaneous tumoursThe Lancet, 1994
- Genetic Risk and Carcinogen Exposure: a Common Inherited Defect of the Carcinogen-Metabolism Gene Glutathione S-Transferase M1 (GSTM1) That Increases Susceptibility to Bladder CancerJNCI Journal of the National Cancer Institute, 1993
- Preliminary criteria for the classification of systemic sclerosis (scleroderma)Arthritis & Rheumatism, 1980